Concepedia

Dirk Iglehart

DI

Statistics

Publications

5

Citations

391

H-Index

5

Active since

1999

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Dirk Iglehart is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

1999–2012

5

Publications

5

Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis

Gerburg M. Wulf, Priti Garg, Yih‐Cherng Liou et al. · The EMBO Journal · 2004 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +14

Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.

Pankaj Seth, Kathryn L. Lunetta, D W Bell et al. · PubMed · 2000 · 88 citations

Medicine, Genetics, Oncology +15

Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin

Janna Sand‐Dejmek, Guillaume Adelmant, Bijan Sobhian et al. · Molecular Cancer · 2011 · 39 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

BRCA1-IRIS Overexpression Promotes Formation of Aggressive Breast Cancers

Yoshiko Shimizu, Hugh Luk, David Horio et al. · PLoS ONE · 2012 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17

Heparin in plasma samples causes nonspecific binding to histones on Western blots

Flavio F. Alcantara, Dirk Iglehart, Robert Ochs · Journal of Immunological Methods · 1999 · 24 citations

Life Sciences, Biochemistry, Molecular Biology +9

1–5 of 5